Categories: Artificial IntelligenceBodyDrugMachine LearningTime
Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.03.2025 | - | $4.5M | - |
Mentions in press and media 3
| Date | Title | Description |
| 20.03.2025 | Olio Labs Raises $4.5M in Funding | Olio Labs, a San Francisco, CA-based provider of a therapeutic design platform, raised $4.5M in funding.
The round was led by Boom Capital and Overwater Ventures, with participation from Pioneer Fund, SciFounders, Scrum Ventures, Y Combinat... |
| 11.03.2024 | ZAKA VC invests in Eigen Therapeutics, an American biotech company | ZAKA VC invests in Eigen Therapeutics, an American biotech company
11 March, 2024, 16:46
Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> -->
Czech family office ZAKA VC has ann... |
| - | Olio Labs | - |
Reviews 0
